Podophyllotoxin derivatives targeting tubulin: An update (2017-2022)

Drug Discov Today. 2023 Aug;28(8):103640. doi: 10.1016/j.drudis.2023.103640. Epub 2023 May 24.

Abstract

Numerous tubulin-targeted podophyllotoxin congeners have been designed and synthesized to overcome the poor water solubility of podophyllotoxin and improve its pharmaceutical characteristics. Understanding the interaction of tubulin with its downstream signal transduction pathways is important for insights into the role of tubulin in the anticancer action of podophyllotoxin-based conjugates. In this review, we provide a detailed account of recent advances in tubulin targeting-podophyllotoxin derivatives with a focus on their antitumor action and potential molecular signaling pathways directly involved in tubulin depolymerization. Such information will be of benefit to researchers designing and developing anticancer drugs derived from podophyllotoxin. Moreover, we also discuss the associated challenges and future opportunities in this field.

Keywords: antitumor activity; mode of action; podophyllotoxin derivatives; signaling pathways; tubulin.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Podophyllotoxin* / pharmacology
  • Podophyllotoxin* / therapeutic use
  • Structure-Activity Relationship
  • Tubulin / metabolism

Substances

  • Podophyllotoxin
  • Tubulin
  • Antineoplastic Agents